Everolimus- versus sirolimus-eluting stents for the treatment of unprotected left main coronary artery stenosis (results from the EXCELLENT registry).

Abstract

BACKGROUND Data concerning the results of 2nd generation DES in the treatment of unprotected left main coronary artery (ULMCA) stenosis are limited. The aim of this study was to evaluate the efficacy and safety of stenting with everolimus- (EES) with sirolimus-eluting stent (SES) for the treatment of ULMCA stenosis in the "real world" setting. METHODS In… (More)
DOI: 10.1016/j.ijcard.2013.03.086

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.